AR093012A1 - Composiciones farmaceuticas en polvo, activas, con enmascaramiento del sabor y procesos para su fabricacion - Google Patents

Composiciones farmaceuticas en polvo, activas, con enmascaramiento del sabor y procesos para su fabricacion

Info

Publication number
AR093012A1
AR093012A1 ARP130103730A ARP130103730A AR093012A1 AR 093012 A1 AR093012 A1 AR 093012A1 AR P130103730 A ARP130103730 A AR P130103730A AR P130103730 A ARP130103730 A AR P130103730A AR 093012 A1 AR093012 A1 AR 093012A1
Authority
AR
Argentina
Prior art keywords
flavor
polymeric layer
mask
powder
processes
Prior art date
Application number
ARP130103730A
Other languages
English (en)
Spanish (es)
Inventor
To Daniel
N Dave Rajesh
Original Assignee
New Jersey Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Jersey Inst Technology filed Critical New Jersey Inst Technology
Publication of AR093012A1 publication Critical patent/AR093012A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glanulating (AREA)
ARP130103730A 2012-10-15 2013-10-15 Composiciones farmaceuticas en polvo, activas, con enmascaramiento del sabor y procesos para su fabricacion AR093012A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13/651,829 US8993041B2 (en) 2012-10-15 2012-10-15 Taste masked active pharmaceutical powder compositions and processes for making them

Publications (1)

Publication Number Publication Date
AR093012A1 true AR093012A1 (es) 2015-05-13

Family

ID=49447846

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130103730A AR093012A1 (es) 2012-10-15 2013-10-15 Composiciones farmaceuticas en polvo, activas, con enmascaramiento del sabor y procesos para su fabricacion

Country Status (7)

Country Link
US (1) US8993041B2 (enExample)
EP (1) EP2906204B1 (enExample)
JP (1) JP6166859B2 (enExample)
CN (1) CN104902879B (enExample)
AR (1) AR093012A1 (enExample)
BR (1) BR112015008284B1 (enExample)
WO (1) WO2014062446A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9107851B2 (en) * 2012-10-15 2015-08-18 New Jersey Institute Of Technology Solventless mixing process for coating pharmaceutical ingredients
CN104968332B (zh) * 2012-11-12 2020-10-20 新泽西理工学院 药用芯-壳复合粉末及其制备方法
CN104587472B (zh) * 2014-12-31 2017-12-15 广东国方医药科技有限公司 一种含纳米SiO2的包衣剂及其制备方法
JP6067154B1 (ja) * 2016-01-25 2017-01-25 株式会社樋口商会 コーティング粒子の製造方法
IL296490B1 (en) * 2016-03-15 2025-09-01 Acer Therapeutics Inc Tasty compositions containing sodium phenylbutyrate and their uses
US11794161B1 (en) 2018-11-21 2023-10-24 Trucapsol, Llc Reduced permeability microcapsules
US12302933B2 (en) 2021-06-25 2025-05-20 Trucapsol Llc Flavor delivery system
US12187829B2 (en) 2021-08-12 2025-01-07 Trucapsol Llc Environmentally biodegradable microcapsules
US11878280B2 (en) 2022-04-19 2024-01-23 Trucapsol Llc Microcapsules comprising natural materials
US11904288B1 (en) 2023-02-13 2024-02-20 Trucapsol Llc Environmentally biodegradable microcapsules
US11969491B1 (en) 2023-02-22 2024-04-30 Trucapsol Llc pH triggered release particle

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63258809A (ja) * 1987-04-16 1988-10-26 Towa Yakuhin Kk 医薬活性成分の放出性にすぐれ、かつ苦味を隠蔽した細粒剤
FI924589A7 (fi) 1990-04-11 1992-10-09 Upjohn Co Ibuprofeenin maun peittäminen leijukerrospäällystyksellä
JPH08333240A (ja) * 1995-06-02 1996-12-17 Shin Etsu Chem Co Ltd 粉末またはペレット状ワックスを用いる無溶媒腸溶性コーティング剤で被覆した腸溶性製剤
GB9515182D0 (en) 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
JP2000053563A (ja) * 1998-08-07 2000-02-22 Bayer Yakuhin Ltd 苦味がマスクされた速放性細粒剤
US6740341B1 (en) * 1998-11-25 2004-05-25 Cima Labs Inc. Taste masking rapid release coating system
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
GB0010446D0 (en) * 2000-04-28 2000-06-14 Glaxo Wellcome Kk Pharmaceutical formulation
US7276249B2 (en) 2002-05-24 2007-10-02 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
US20040137156A1 (en) * 2002-07-25 2004-07-15 Lee Ernest J Coated solid dosage form and method for preparing same
US8252370B1 (en) 2005-10-20 2012-08-28 The United States Of America As Represented By The Secretary Of The Army Continuous high-speed coating of finely ground particulates
DE102005062270A1 (de) * 2005-12-24 2007-06-28 Bayer Technology Services Gmbh Geschmacksmaskierung von Pulvern
PT2094382E (pt) * 2006-11-10 2012-07-24 New Jersey Tech Inst Sistemas e métodos de leito fluidizado incluindo fluxo gasoso secundário
EP2201939A1 (en) 2008-12-25 2010-06-30 Zentiva Kimyasal Ürünler Sanayi ve Ticaret A.S. Method for producing coated spiramycin and novel formulations containing the same
CN106390129A (zh) * 2009-05-01 2017-02-15 艾戴尔医药公司 含有高剂量和低剂量药物的组合的口腔崩解片组合物

Also Published As

Publication number Publication date
US8993041B2 (en) 2015-03-31
BR112015008284B1 (pt) 2022-05-24
US20140106058A1 (en) 2014-04-17
BR112015008284A2 (pt) 2017-07-04
WO2014062446A1 (en) 2014-04-24
CN104902879B (zh) 2018-07-17
EP2906204B1 (en) 2022-09-28
JP6166859B2 (ja) 2017-07-19
CN104902879A (zh) 2015-09-09
EP2906204A1 (en) 2015-08-19
JP2015533164A (ja) 2015-11-19

Similar Documents

Publication Publication Date Title
AR093012A1 (es) Composiciones farmaceuticas en polvo, activas, con enmascaramiento del sabor y procesos para su fabricacion
CO2017012362A2 (es) Formas de dosificación sólida que comprenden palbociclib, un ácido hidrosoluble y un portador farmacéuticamente aceptable y métodos para su produccion y uso
AR080662A1 (es) Forma de dosis oral solida con contenido de nanoparticulas y proceso de formulacion de la misma utilizando gelatina de pescado
BR112015023629A2 (pt) formulação de acetato de abiraterona
HK1213503A1 (zh) 药物递送医疗装置
DOP2015000006A (es) Formulaciones de etanercept que muestran una marcada reducción de la cantidad de partículas subvisibles
AR085120A1 (es) Formulaciones de particulas en polvo seco que contienen dos o mas ingredientes activos para el tratamiento de las enfermedades obstructivas o inflamatorias de las vias respiratorias
CO7310520A2 (es) Nanopartícula polimérica de finasterida y minoxidil proceso de preparación, suspensión acuosa conteniendo la misma,composición farmaceútica y su uso
CO6690744A2 (es) Formulación de polvo seco que comprende un inhibidor de fosfodiesterasa
HK1212616A1 (zh) 多孔载体颗粒和微粒化药物的可吸入团聚物
WO2015152693A3 (ko) 신규 이중 나선 올리고 rna 및 이를 포함하는 섬유증 또는 호흡기 질환의 예방 또는 치료용 약학조성물
MX2016007134A (es) Composiciones farmaceuticas mejoradas de pimobendan.
WO2019090030A8 (en) Hydrophobic ion pairing and flash nanoprecipitation for formation of controlled-release nanocarrier formulations
AR083208A1 (es) Uso de estearato de magnesio en formulaciones de polvo seco para inhalacion
UY35003A (es) Nanopartícula polimérica de finasterida, suspensión acuosa conteniendo a la misma, composición para tratamiento de alopecia,proceso de preparación de dicha composición, y su uso
CL2013000677A1 (es) Composicion farmaceutica en forma de tabletas que comprenden microgranulos gastrointestinales que contienen 100 a 800 mg de rifaximina, hasta 30% p/p de excipientes extragranulares y un recubrimiento formador de pelicula; y uso para tratar una enfermedad infecciosa y/o inflamatoria del intestino, tal como la enfermedad de crohn.
MX2018005384A (es) Composiciones y metodos para fabricar microparticulas de proteina.
BR112014016472A2 (pt) formulação farmacêutica estável para administração oral que compreende levocetirizina ou um sal farmaceuticamente aceitável da mesma e montelukast ou um sal farmaceuticamente aceitável do mesmo
CR20140540A (es) Nueva forma de dosificación y formulación de abediterol
BR112014009438A2 (pt) composição farmacêutica para administração oral, e, método de preparação da composição farmacêutica para administração oral
CY1124635T1 (el) Ξηρες φαρμακευτικες συνθεσεις που περιεχουν νανοσωματιδια ενεργου παραγοντα δεσμευμενα σε σωματιδια φορεα
HK1216839A1 (zh) 调整释放制剂
DOP2015000071A (es) Fármaco combinado que comprende gemigliptina y metformina, y método para su preparación
MX2017013636A (es) Combinacion de dosis fija resistente a la manipulacion que proporciona una liberacion rapida de dos farmacos desde diferentes particulas.
HK1203050A1 (en) Novel dosage and formulation

Legal Events

Date Code Title Description
FC Refusal